These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28722211)

  • 1. Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program.
    Hartung DM; Ahmed SM; Middleton L; Van Otterloo J; Zhang K; Keast S; Kim H; Johnston K; Deyo RA
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1053-1060. PubMed ID: 28722211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.
    El Ibrahimi S; Hallvik S; Johnston K; Leichtling G; Choo E; Hartung DM
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1168-1174. PubMed ID: 32939909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the Direct Costs of Outpatient Opioid Prescriptions: A Retrospective Analysis of Data from the Rhode Island Prescription Drug Monitoring Program.
    Aroke H; Buchanan A; Wen X; Ragosta P; Koziol J; Kogut S
    J Manag Care Spec Pharm; 2018 Mar; 24(3):214-224. PubMed ID: 29485950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.
    Cochran G; Lo-Ciganic WH; Gellad WF; Gordon AJ; Cole E; Lobo C; Frazier W; Zheng P; Chang CH; Kelley D; Donohue JM
    J Manag Care Spec Pharm; 2018 Sep; 24(9):875-885. PubMed ID: 30156454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trajectories of dispensed prescription opioids among beneficiaries enrolled in a Medicaid controlled substance "lock-in" program.
    Naumann RB; Marshall SW; Gottfredson NC; Lund JL; Ringwalt CL; Skinner AC
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):16-24. PubMed ID: 29700904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Abuse-Deterrent or Tamper-Resistant Opioid Formulations on Overall Health Care Expenditures in a State Medicaid Program.
    Keast SL; Owora A; Nesser N; Farmer K
    J Manag Care Spec Pharm; 2016 Apr; 22(4):347-56. PubMed ID: 27023688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental Effect of the Addition of Prescriber Restrictions on a State Medicaid's Pharmacy-Only Patient Review and Restriction Program.
    Keast SL; Pham T; Teel A; Nesser NJ
    J Manag Care Spec Pharm; 2017 Aug; 23(8):875-883. PubMed ID: 28737989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of an opioid management initiative by a state Medicaid program.
    Garcia MM; Angelini MC; Thomas T; Lenz K; Jeffrey P
    J Manag Care Spec Pharm; 2014 May; 20(5):447-54. PubMed ID: 24761816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.
    Jayawardhana J; Abraham AJ; Perri M
    J Manag Care Spec Pharm; 2018 Sep; 24(9):886-894. PubMed ID: 30156455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating short- and long-term impacts of a Medicaid "lock-in" program on opioid and benzodiazepine prescriptions dispensed to beneficiaries.
    Naumann RB; Marshall SW; Lund JL; Gottfredson NC; Ringwalt CL; Skinner AC
    Drug Alcohol Depend; 2018 Jan; 182():112-119. PubMed ID: 29150151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lock-in loophole: Using mixed methods to explain patient circumvention of a Medicaid opioid restriction program.
    Roberts AW; Skinner AC; Lauffenburger JC; Galt KA
    Subst Abus; 2020; 41(4):510-518. PubMed ID: 31644398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping prescription drug monitoring program data to self-report measures of non-medical prescription opioid use in community pharmacy settings.
    Charron E; Brooks JH; Peterson KT; Akinwolere OG; Winhusen T; Cochran G
    Res Social Adm Pharm; 2023 Aug; 19(8):1171-1177. PubMed ID: 37142474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Concentration of Opioid Prescriptions by Providers and Among Patients in the Oregon Medicaid Program.
    Kim H; Hartung DM; Jacob RL; McCarty D; McConnell KJ
    Psychiatr Serv; 2016 Apr; 67(4):397-404. PubMed ID: 26766755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion to Persistent or High-Risk Opioid Use After a New Prescription From the Emergency Department: Evidence From Washington Medicaid Beneficiaries.
    Meisel ZF; Lupulescu-Mann N; Charlesworth CJ; Kim H; Sun BC
    Ann Emerg Med; 2019 Nov; 74(5):611-621. PubMed ID: 31229392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsolicited Reporting to Prescribers of Opioid Analgesics by a State Prescription Drug Monitoring Program: An Observational Study with Matched Comparison Group.
    Young LD; Kreiner PW; Panas L
    Pain Med; 2018 Jul; 19(7):1396-1407. PubMed ID: 28383713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Opioid Prescription and Subsequent High-Risk Opioid Use: a National Study of Privately Insured and Medicare Advantage Adults.
    Zhang Y; Johnson P; Jeng PJ; Reid MC; Witkin LR; Schackman BR; Ancker JS; Bao Y
    J Gen Intern Med; 2018 Dec; 33(12):2156-2162. PubMed ID: 30206790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids.
    Chua KP; Brummett CM; Conti RM; Haffajee RL; Prosser LA; Bohnert ASB
    JAMA Netw Open; 2019 May; 2(5):e193673. PubMed ID: 31074819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.